{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T19:21:55Z","timestamp":1774725715661,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1006004","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000}}],"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009053","name":"DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/S\/14\/1\/501307"],"award-info":[{"award-number":["IA\/S\/14\/1\/501307"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1006004","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T18:23:41Z","timestamp":1518805421000},"page":"e1006004","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents"],"prefix":"10.1371","volume":"14","author":[{"given":"Vipul","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-9828","authenticated-orcid":true,"given":"Narendra M.","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,2,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrmicro3352","article-title":"Eradicating HIV-1 infection: seeking to clear a persistent pathogen","volume":"12","author":"NM Archin","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"D Finzi","year":"1999","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1073\/pnas.0804192105","article-title":"HIV rebounds from latently infected cells, rather than from continuing low-level replication","volume":"105","author":"B Joos","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"YC Ho","year":"2013","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature13594","article-title":"Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys","volume":"512","author":"JB Whitney","year":"2014","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"JD Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2005.06.006","article-title":"Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity","volume":"122","author":"LS Weinberger","year":"2005","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00002030-200003100-00013","article-title":"Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression","volume":"14","author":"L Ruiz","year":"2000","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMc1413931","article-title":"Viremic relapse after HIV-1 remission in a perinatally infected child","volume":"372","author":"K Luzuriaga","year":"2015","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cell.2013.09.044","article-title":"An integrated overview of HIV-1 latency","volume":"155","author":"S Ruelas Debbie","year":"2013","journal-title":"Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"aaf6517","DOI":"10.1126\/science.aaf6517","article-title":"Latency reversal and viral clearance to cure HIV-1","volume":"353","author":"DM Margolis","year":"2016","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tim.2015.11.003","article-title":"Reversal of latency as part of a cure for HIV-1","volume":"24","author":"TA Rasmussen","year":"2016","journal-title":"Trends Microbiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nm.4108","article-title":"International AIDS Society global scientific strategy: towards an HIV cure 2016","volume":"22","author":"SG Deeks","year":"2016","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/infdis\/jiw618","article-title":"Proviral latency, persistent human immunodeficiency virus infection, and the development of latency reversing agents","volume":"215","author":"DM Margolis","year":"2017","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.cell.2015.02.009","article-title":"A hardwired HIV latency program","volume":"160","author":"BS Razooky","year":"2015","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.chom.2016.11.001","article-title":"The mTOR complex controls HIV latency","volume":"20","author":"E Besnard","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/aid.2014.0199","article-title":"Targeting NF-kappaB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency","volume":"31","author":"G Jiang","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/COH.0b013e328341242d","article-title":"Histone deacetylase inhibitors and HIV latency","volume":"6","author":"DM Margolis","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"NM Archin","year":"2012","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e1005142","DOI":"10.1371\/journal.ppat.1005142","article-title":"The depsipeptide romidepsin reverses HIV-1 latency in vivo","volume":"11","author":"OS Sogaard","year":"2015","journal-title":"PLoS Pathog"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1016\/S2352-3018(15)00226-X","article-title":"Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study","volume":"2","author":"JH Elliott","year":"2015","journal-title":"Lancet HIV"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/QAD.0000000000001064","article-title":"Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy","volume":"30","author":"C Gutierrez","year":"2016","journal-title":"AIDS"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2352-3018(14)70014-1","article-title":"Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1\/2, single group, clinical trial","volume":"1","author":"TA Rasmussen","year":"2014","journal-title":"Lancet HIV"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"ofw189","DOI":"10.1093\/ofid\/ofw189","article-title":"Ongoing clinical trials of human immunodeficiency virus latency-reversing and immunomodulatory agents","volume":"3","author":"HM Delagreverie","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"CK Bullen","year":"2014","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1073\/pnas.1402873111","article-title":"Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy","volume":"111","author":"AR Cillo","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4(+) T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics","volume":"214","author":"NN Hosmane","year":"2017","journal-title":"J Exp Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1172\/JCI80142","article-title":"Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations","volume":"125","author":"GM Laird","year":"2015","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e1005063","DOI":"10.1371\/journal.ppat.1005063","article-title":"An in-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression","volume":"11","author":"G Darcis","year":"2015","journal-title":"PLoS Pathog"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"11091","DOI":"10.1128\/JVI.76.21.11091-11103.2002","article-title":"Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies","volume":"76","author":"V Quivy","year":"2002","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e6093","DOI":"10.1371\/journal.pone.0006093","article-title":"Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection","volume":"4","author":"S Reuse","year":"2009","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1128\/JVI.00161-10","article-title":"Combinatorial latency reactivation for HIV-1 subtypes and variants","volume":"84","author":"JC Burnett","year":"2010","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2174\/157016210793499312","article-title":"Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency","volume":"8","author":"M Perez","year":"2010","journal-title":"Curr HIV Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"16445","DOI":"10.1038\/srep16445","article-title":"Synergistic activation of latent HIV-1 expression by novel histone deacetylase inhibitors and bryostatin-1","volume":"5","author":"M Martinez-Bonet","year":"2015","journal-title":"Sci Rep"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e1005066","DOI":"10.1371\/journal.ppat.1005066","article-title":"Synergistic reactivation of latent HIV expression by ingenol-3-angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation","volume":"11","author":"G Jiang","year":"2015","journal-title":"PLoS Pathog"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.15252\/emmm.201505557","article-title":"Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1","volume":"8","author":"S Bouchat","year":"2016","journal-title":"EMBO Mol Med"},{"key":"ref37","first-page":"5173205","article-title":"HMBA enhances prostratin-induced activation of latent HIV-1 via suppressing the expression of negative feedback regulator A20\/TNFAIP3 in NF-kappaB signaling","volume":"2016","author":"D Chen","year":"2016","journal-title":"Biomed Res Int"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e0168027","DOI":"10.1371\/journal.pone.0168027","article-title":"Euphorbia kansui reactivates latent HIV","volume":"11","author":"DC Cary","year":"2016","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nsmb.3328","article-title":"Position effects influence HIV latency reversal","volume":"24","author":"HC Chen","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/msb.2010.4","article-title":"Intracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy","volume":"6","author":"CL Althaus","year":"2010","journal-title":"Mol Syst Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.1250220","article-title":"Screening for noise in gene expression identifies drug synergies","volume":"344","author":"RD Dar","year":"2014","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"17661","DOI":"10.1038\/srep17661","article-title":"Distinct promoter activation mechanisms modulate noise-driven HIV gene expression","volume":"5","author":"AK Chavali","year":"2015","journal-title":"Sci Rep"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.pbio.0050009","article-title":"An HIV feedback resistor: auto-regulatory circuit deactivator and noise buffer","volume":"5","author":"LS Weinberger","year":"2007","journal-title":"PLoS Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"13475","DOI":"10.1073\/pnas.1406663111","article-title":"Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1","volume":"111","author":"AL Hill","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e1005535","DOI":"10.1371\/journal.ppat.1005535","article-title":"Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV","volume":"12","author":"AL Hill","year":"2016","journal-title":"PLoS Pathog"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e1002033","DOI":"10.1371\/journal.pcbi.1002033","article-title":"A stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patients","volume":"7","author":"JM Conway","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cell.2015.02.017","article-title":"An evolutionary role for HIV latency in enhancing viral transmission","volume":"160","author":"IM Rouzine","year":"2015","journal-title":"Cell"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e1005000","DOI":"10.1371\/journal.ppat.1005000","article-title":"HIV Reactivation from latency after treatment interruption occurs on average every 5\u20138 days\u2014Implications for HIV remission","volume":"11","author":"M Pinkevych","year":"2015","journal-title":"PLoS Pathog"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-[kappa]B regulation in the immune system","volume":"2","author":"Q Li","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jmb.2009.08.023","article-title":"Structural basis of HIV-1 activation by NF-kappaB\u2014a higher-order complex of p50:RelA bound to the HIV-1 LTR","volume":"393","author":"JC Stroud","year":"2009","journal-title":"J Mol Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1742-4690-10-67","article-title":"HIV-1 transcription and latency: an update","volume":"10","author":"C Van Lint","year":"2013","journal-title":"Retrovirology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/aid.1992.8.245","article-title":"Binding of NF-kB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity","volume":"8","author":"C Doppler","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"a006916","DOI":"10.1101\/cshperspect.a006916","article-title":"Transcriptional and posttranscriptional regulation of HIV-1 gene expression","volume":"2","author":"J Karn","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.physchem.58.032806.104637","article-title":"Stochastic simulation of chemical kinetics","volume":"58","author":"DT Gillespie","year":"2007","journal-title":"Annu Rev Phys Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/aid.2014.0224","article-title":"I am the Berlin patient: a personal reflection","volume":"31","author":"TR Brown","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e1003211","DOI":"10.1371\/journal.ppat.1003211","article-title":"Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study","volume":"9","author":"A Saez-Cirion","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1073\/pnas.1419162112","article-title":"Post-treatment control of HIV infection","volume":"112","author":"JM Conway","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"14400","DOI":"10.1074\/jbc.M113.464834","article-title":"Histone deacetylase inhibitors (HDACis) that release the positive transcription elongation factor b (P-TEFb) from its inhibitory complex also activate HIV transcription","volume":"288","author":"K Bartholomeeusen","year":"2013","journal-title":"J Biol Chem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.molcel.2010.04.012","article-title":"HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP","volume":"38","author":"B Sobhian","year":"2010","journal-title":"Mol Cell"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1093\/nar\/gkr1224","article-title":"Human immunodeficiency virus-1 Tat activates NF-\u03baB via physical interaction with I\u03baB-\u03b1 and p65","volume":"40","author":"G Fiume","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12195-014-0336-9","article-title":"Quantitative evaluation and optimization of co-drugging to improve anti-HIV latency therapy","volume":"7","author":"VC Wong","year":"2014","journal-title":"Cell Mol Bioeng"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"e1003834","DOI":"10.1371\/journal.ppat.1003834","article-title":"An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients","volume":"9","author":"CA Spina","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/bioinformatics\/btr401","article-title":"StochKit2: software for discrete stochastic simulation of biochemical systems with events","volume":"27","author":"KR Sanft","year":"2011","journal-title":"Bioinformatics"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1107729108","article-title":"Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule","volume":"108","author":"L Josefsson","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/978-1-62703-050-2_21","article-title":"Mechanism-based pharmacodynamic modeling","volume":"929","author":"MA Felmlee","year":"2012","journal-title":"Methods Mol Biol"},{"key":"ref66","first-page":"57","article-title":"Python: A programming language for software integration and development","volume":"17","author":"MF Sanner","year":"1999","journal-title":"J Mol Graph Model"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: A 2D graphics environment","volume":"9","author":"JD Hunter","year":"2007","journal-title":"Comput Sci Eng"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1126\/science.1113319","article-title":"Stimulus specificity of gene expression programs determined by temporal control of IKK activity","volume":"309","author":"SL Werner","year":"2005","journal-title":"Science"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1126\/science.1199784","article-title":"Proteome half-life dynamics in living human cells","volume":"331","author":"E Eden","year":"2011","journal-title":"Science"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1006004","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:33:37Z","timestamp":1589034817000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006004"}},"subtitle":[],"editor":[{"given":"Avner","family":"Schlessinger","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,16]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1006004","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1006004","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,16]]}}}